Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RDM1 pseudogene 1 (RDM1P1) is a human pseudogene related in sequence to the RAD52 motif-containing 1 (RDM1) gene. Unlike protein-coding genes, pseudogenes such as RDM1P1 are typically non-functional genomic sequences arising from duplication or retrotransposition events and often contain disabling mutations or are transcriptionally silent[5][9]. While some pseudogenes can regulate expression of their parental genes at the RNA level—such as acting as competing endogenous RNAs (ceRNAs) or miRNA decoys—no specific functional or disease association is reported for RDM1P1[3][5][8]. The canonical RDM1 gene (RAD52 motif containing 1) codes for a DNA/RNA-binding protein involved in DNA double-strand break repair, but RDM1P1 itself is not known to encode a functional protein nor to serve as a therapeutic or diagnostic target[1][6]. Key context: - RDM1P1 is a pseudogene, not an active gene or known therapeutic target[5][9]. - No evidence supports its role as a biomarker, target, or direct disease association. - General functions described for some pseudogenes (not specific to RDM1P1) include RNA-based regulation such as miRNA sponging, but these roles are gene-specific and require direct evidence[3][5]. - If you are seeking information about the protein-coding RDM1 gene, not the pseudogene, substantially more functional and disease-related information is available[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RDM1 pseudogene 1 (RDM1P1).